12:00 AM
Oct 11, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

IDEC-114: Began Phase I/II testing

Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif.
Product: IDEC-114
Business: Autoimmune/Inflammation, Dermatology
Therapeutic category: Antibody, Immune...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >